GB0201611D0 - Transgenic animal - Google Patents

Transgenic animal

Info

Publication number: GB0201611D0
Authority: GB; United Kingdom
Prior art keywords: transgenic animal; transgenic; animal
Prior art date: 2002-01-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0201611.1A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-24

Filing date

2002-01-24

Publication date

2002-03-13

2002-01-24 Application filed by Individual filed Critical Individual

2002-01-24 Priority to GBGB0201611.1A priority Critical patent/GB0201611D0/en

2002-03-13 Publication of GB0201611D0 publication Critical patent/GB0201611D0/en

2003-01-24 Priority to EP03731802A priority patent/EP1470222A2/en

2003-01-24 Priority to PCT/IB2003/000653 priority patent/WO2003062415A2/en

2003-01-24 Priority to AU2003237975A priority patent/AU2003237975A1/en

2003-01-24 Priority to CA002474030A priority patent/CA2474030A1/en

2004-07-19 Priority to US10/894,194 priority patent/US20050108780A1/en

2006-03-09 Priority to US11/372,250 priority patent/US20060150261A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/20—Animal model comprising regulated expression system
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
- A01K2267/025—Animal producing cells or organs for transplantation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/80—Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Plant Pathology (AREA)
Toxicology (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Oncology (AREA)
Veterinary Medicine (AREA)
Physics & Mathematics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

GBGB0201611.1A 2002-01-24 2002-01-24 Transgenic animal Ceased GB0201611D0 (en)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
GBGB0201611.1A GB0201611D0 (en)	2002-01-24	2002-01-24	Transgenic animal
EP03731802A EP1470222A2 (en)	2002-01-24	2003-01-24	Transgenic animal comprising intracellular immunoglobins for xenotransplantation
PCT/IB2003/000653 WO2003062415A2 (en)	2002-01-24	2003-01-24	Transgenic animal comprising intracellular immunoglobins for xenotransplantation
AU2003237975A AU2003237975A1 (en)	2002-01-24	2003-01-24	Transgenic animal comprising intracellular immunoglobins for xenotransplantation
CA002474030A CA2474030A1 (en)	2002-01-24	2003-01-24	Transgenic animal comprising intracellular immunoglobins for xenotransplantation
US10/894,194 US20050108780A1 (en)	2002-01-24	2004-07-19	Intracellular antibodies for a retrovirus protein
US11/372,250 US20060150261A1 (en)	2002-01-24	2006-03-09	Intracellular antibodies for a retrovirus protein

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0201611.1A GB0201611D0 (en)	2002-01-24	2002-01-24	Transgenic animal

Publications (1)

Publication Number	Publication Date
GB0201611D0 true GB0201611D0 (en)	2002-03-13

Family

ID=9929668

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0201611.1A Ceased GB0201611D0 (en)	2002-01-24	2002-01-24	Transgenic animal

Country Status (5)

Country	Link
EP (1)	EP1470222A2 (en)
AU (1)	AU2003237975A1 (en)
CA (1)	CA2474030A1 (en)
GB (1)	GB0201611D0 (en)
WO (1)	WO2003062415A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2846667B1 (en) *	2002-11-06	2004-12-31	Pasteur Institut	VARIABLE FRAGMENTS OF SINGLE-CHAIN CAMELIDE ANTIBODIES DIRECTED AGAINST BETA-AMYLOID PEPTIDE 1-42 AND THEIR APPLICATIONS FOR DIAGNOSIS AND TREATMENT OF NEUROAGREGATIVE DISEASES
GB0522460D0 (en) *	2005-11-03	2005-12-14	Prendergast Patrick T	Composition and method for the treatment of avian influenza
SG10201800800YA (en)	2013-05-06	2018-03-28	Scholar Rock Inc	Compositions and methods for growth factor modulation
US9879087B2 (en)	2014-11-12	2018-01-30	Siamab Therapeutics, Inc.	Glycan-interacting compounds and methods of use
EP3218005B1 (en)	2014-11-12	2023-01-04	Seagen Inc.	Glycan-interacting compounds and methods of use
JP7066613B2 (en)	2015-11-12	2022-05-13	シージェンインコーポレイテッド	Glycan interacting compounds and how to use
EP3541847A4 (en)	2016-11-17	2020-07-08	Seattle Genetics, Inc.	Glycan-interacting compounds and methods of use
JP2020510671A (en)	2017-03-03	2020-04-09	シアトルジェネティックス，インコーポレイテッド	Glycan interacting compounds and methods of use

2002
- 2002-01-24 GB GBGB0201611.1A patent/GB0201611D0/en not_active Ceased
2003
- 2003-01-24 EP EP03731802A patent/EP1470222A2/en not_active Withdrawn
- 2003-01-24 CA CA002474030A patent/CA2474030A1/en not_active Abandoned
- 2003-01-24 WO PCT/IB2003/000653 patent/WO2003062415A2/en not_active Application Discontinuation
- 2003-01-24 AU AU2003237975A patent/AU2003237975A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2474030A1 (en)	2003-07-31
EP1470222A2 (en)	2004-10-27
AU2003237975A1 (en)	2003-09-02
WO2003062415A2 (en)	2003-07-31
WO2003062415A3 (en)	2004-06-03

Publication	Publication Date	Title
AU2003290199A8 (en)	2004-03-11	Improved cat litter
AU153733S (en)	2003-11-17	Five-meal animal feeder
AU150710S (en)	2003-02-18	Animal chew
GB0201611D0 (en)	2002-03-13	Transgenic animal
GB2388289B (en)	2005-07-06	Bait stop
AU152402S (en)	2003-07-22	Animal feeder
GB0207830D0 (en)	2002-05-15	Animal composition
GB0229914D0 (en)	2003-01-29	Fishing device
GB2384680B (en)	2005-03-09	Dog leash
AU151688S (en)	2003-05-13	Leash
AU155208S (en)	2004-04-20	An animal chew
GB0219857D0 (en)	2002-10-02	An animal stall
GB0218699D0 (en)	2002-09-18	Animal spooker
GB0221853D0 (en)	2002-10-30	Animal scarer
HK1047858A2 (en)	2003-02-21	Animal trap
CA94951S (en)	2002-03-15	Halter for animals
AU155821S (en)	2004-07-01	Animal foofstuff
GB0216729D0 (en)	2002-08-28	Animal models
GB2392610B (en)	2005-12-21	Animal grooming device
GB0219492D0 (en)	2002-10-02	Transgenic organisms
GB0217083D0 (en)	2002-09-04	Transgenic organisms
PL355435A1 (en)	2004-02-23	Non-foul fishing set
TW532070U (en)	2003-05-11	Fishhook
AU149909S (en)	2002-11-26	Animal chew
GB0226793D0 (en)	2002-12-24	Bait containor-dispenser

Legal Events

Date	Code	Title	Description
2003-04-16	AT	Applications terminated before publication under section 16(1)